Digital Support for Reducing Salt Intake in Kidney Disease
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
- Age
- 18 – 74
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 104 (estimated)
- Sponsor
- Steno Diabetes Center Copenhagen · Other
This trial is looking for people with type 2 diabetes and kidney disease to see if a digital program can help them eat less salt. Participants will need to be able to use a digital platform and follow some dietary guidelines.
You may be able to join if
- I have been diagnosed with type 2 diabetes
- I am between 18 and 74 years old
- My BMI is less than 35
- My kidney function (eGFR) is between 30 and 59 ml/min
- I have stable medication for at least 3 months
- I can read and understand Danish
You may not be able to join if
- I have type 1 diabetes or another type of diabetes
- I follow a vegan diet
- I currently have active cancer
- I have short bowel syndrome or celiac disease
- I use sodium chloride tablets
- I do not have access to a digital platform
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
Loading trial locations…
No contact information available.